Of the seven remaining ALT-negative tumors that lacked TERT rearrangement, one tumor harbored amplification of MYC, a known transcriptional activator of TERT31, and this tumor displayed elevated TERT expression (Fig. 2e, arrow). This evidence concerns the gene MYC and neoplasm.